ChemPartner PharmaTech Co., Ltd. — Investor Relations & Filings
ChemPartner PharmaTech Co., Ltd. is a global research and development organization providing comprehensive drug discovery and development services. Operating as a Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), the company supports pharmaceutical and biotechnology clients through an integrated service platform. Core capabilities include medicinal chemistry, biology, pharmacology, drug metabolism and pharmacokinetics (DMPK), and toxicology. The organization also offers specialized expertise in biologics discovery, protein engineering, and antibody development. ChemPartner facilitates the transition from early-stage research to clinical development through its pharmaceutical development and manufacturing capabilities, utilizing advanced technology to accelerate the discovery and production of novel therapeutic agents.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于召开2021年第二次临时股东大会的通知 | 2021-06-25 | Chinese | |
| 关于向关联方借款暨关联交易的公告 | 2021-06-25 | Chinese | |
| 第四届监事会第三十次会议决议公告 | 2021-06-25 | Chinese | |
| 睿智医药科技股份有限公司因《盈利预测补偿协议》而进行资产减值测试涉及的上海睿智化学研究有限公司90%股权的股东部分权益资产评估报告 | 2021-06-25 | Chinese | |
| 第四届董事会第三十五次会议决议公告 | 2021-06-25 | Chinese | |
| 关于公司控股股东部分股份质押展期的公告 | 2021-06-16 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2021
15 filings
| |||||
| 36035522 | 关于召开2021年第二次临时股东大会的通知 | 2021-06-25 | Chinese | ||
| 36035510 | 关于向关联方借款暨关联交易的公告 | 2021-06-25 | Chinese | ||
| 36035504 | 第四届监事会第三十次会议决议公告 | 2021-06-25 | Chinese | ||
| 36035496 | 睿智医药科技股份有限公司因《盈利预测补偿协议》而进行资产减值测试涉及的上海睿智化学研究有限公司90%股权的股东部分权益资产评估报告 | 2021-06-25 | Chinese | ||
| 36035482 | 第四届董事会第三十五次会议决议公告 | 2021-06-25 | Chinese | ||
| 36035472 | 关于公司控股股东部分股份质押展期的公告 | 2021-06-16 | Chinese | ||
| 36035465 | 关于回购公司股份的进展公告 | 2021-06-01 | Chinese | ||
| 36035455 | 2020年年度权益分派实施公告 | 2021-05-25 | Chinese | ||
| 36035448 | 2020年年度股东大会决议公告 | 2021-05-20 | Chinese | ||
| 36035443 | 睿智医药：2020年年度股东大会法律意见书 | 2021-05-20 | Chinese | ||
| 36035427 | 关于举办2020年度网上业绩说明会的通知 | 2021-05-20 | Chinese | ||
| 36035416 | 关于持股5%以上股东减持比例达到1%的公告 | 2021-05-11 | Chinese | ||
| 36035408 | 关于收到业绩补偿款暨业绩承诺履行完毕的公告 | 2021-05-10 | Chinese | ||
| 36035400 | 关于回购公司股份的进展公告 | 2021-05-06 | Chinese | ||
| 36035389 | 一季报披露提示性公告 | 2021-04-28 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova (Taiwan) Corporation
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
ChemPartner PharmaTech Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55161/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55161 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55161 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55161 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55161}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ChemPartner PharmaTech Co., Ltd. (id: 55161)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.